Pictured: John P. Groetelaars
Hill-Rom Holdings, Inc, a global medical technology company, announced on April 27, 2018 that John P. Groetelaars has been appointed as the president and chief executive fficer of the company. He succeeds John J. Greisch, who has been president and CEO at the company since 2010.
John P. Groetelaars comes to Hill-Rom from Becton, Dickinson and Company, where he has held the position of executive vice president and president of the Interventional Segment following the acquisition of C.R. Bard in 2017.
Groetelaars will assume his position, as well as join the company’s board of directors, on May 14, 2018, following his departure from Becton, Dickinson and Company on May 1st. John Greisch will retire from Hill-Rom and its board of directors on May 14th as well.
